CN Stock MarketDetailed Quotes

603229 Zhejiang Ausun Pharmaceutical

Watchlist
  • 8.63
  • -0.05-0.58%
Not Open Dec 10 15:00 CST
7.17BMarket Cap27.84P/E (TTM)

About Zhejiang Ausun Pharmaceutical Company

The company was founded in April 2010 and listed on the Shanghai Stock Exchange on May 9, 2017. The company is a national high-tech enterprise. Currently, the company has platforms such as national postdoctoral workstations, Zhejiang Key Enterprise Research Institute, Provincial Enterprise Technology Center, and Provincial R&D Center. The company is mainly engaged in R&D, production and sales of formulations, specialty APIs and pharmaceutical intermediates, as well as providing customers with customized production and R&D services. The company's main products are preparations, specialty APIs and pharmaceutical intermediates.

Company Profile

Short Name-A奥翔药业
Symbol-A603229
Company NameZhejiang Ausun Pharmaceutical Co., Ltd.
Listing DateMay 9, 2017
Issue Price7.81
Shares Offered40.00M share(s)
FoundedApr 22, 2010
Listed ExchangeSH Stock Exchange
Legal Representativezhiguo zheng
General Managerzhiguo zheng
Secretaryxiaochen ying
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativetuantuan wang
Legal CounselBeijing Hairun Tianrui Law Firm
Employees1117
Phone0576-85589367
Office AddressNo. 5 Donghai Fourth Avenue, Linhai Park, Zhejiang Chemical Raw Materials Base
Zip Code317016
Registered AddressNo. 5 Donghai Fourth Avenue, Linhai Park, Taizhou Chemical Raw Materials Base, Zhejiang Province
Fax0576-85589367
Emailboard@ausunpharm.com
Business License331082000047854
BusinessManufacture of APIs and tablets (operated with a valid license); manufacture of organic intermediates (excluding hazardous chemicals and chemicals prone to drug production); wholesale and import and export of pharmaceutical and chemical products (excluding hazardous chemicals and chemicals prone to drug production), technical research and consulting services for pharmaceutical and chemical products. The above relates to licensed certificate operations. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • zhiguo zheng
  • Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy Committee
  • 1.12M
  • yu liu
  • Directors, Audit Committee Member
  • 340.20K
  • huadong zhang
  • Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
  • 556.90K
  • hemin zhu
  • Directors
  • 366.00K
  • shilan zheng
  • Directors
  • 302.60K
  • fei chen
  • Directors
  • --
  • lirong yang
  • Independent Directors, Strategy Committee Member, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
  • --
  • shuxing yang
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member
  • --
  • mingmin luo
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 70.00K
  • xiaochen ying
  • Board Secretary
  • 752.80K
  • tuantuan wang
  • Securities Affairs Representative, Audit Manager
  • --
  • haiyan xu
  • Chairman of the Supervisory Board, Employee Supervisors
  • 204.60K
  • chunguang dai
  • Auditors
  • 182.80K
  • guanneng yu
  • Auditors
  • 473.80K
  • yu zhong
  • Deputy General Manager
  • 530.50K
  • kai gao
  • Deputy General Manager
  • 671.50K
  • dingmin zhu
  • Chief Financial Officer
  • 557.90K
Heat List
CN
Overall
Symbol
Price
% Chg

No Data